Document is current
Any future updates will be listed below
-
Authors
Cawthorne, Christopher
Maguire, Paul
Mercier, Joel
Sciberras, David
Serdons, Kim
Bormans, Guy
de Hoon, Jan
Van Laere, Koen
Koole, Michel https://orcid.org/0000-0001-5862-640X
-
Funding
Funding for this research was provided by:
FWO (I001719N)
- License Information
-
More Information
Article History
Received: 9 December 2020
Accepted: 13 April 2021
First Online: 23 April 2021
Declarations
:
: This study was part of a larger phase I, single-center, open-label study (EudraCT Number 2016-001190-32). Written informed consent was obtained for each subject. The study was approved by the local ethical committee and conducted in accordance with the most recent version of the Declaration of Helsinki.
: Written informed consent obtained for each subject included publication of their data and images.
: The study was sponsored by UCB Pharma, Belgium, who also delivered precursor and reference compound for [<sup>11</sup>C]-UCB-J. No other potential conflicts of interest relevant to this manuscript were reported.
